Karuna Therapeutics Stock Equity Positions Weight
KRTXDelisted Stock | USD 203.11 1.46 0.71% |
Karuna Therapeutics fundamentals help investors to digest information that contributes to Karuna Therapeutics' financial success or failures. It also enables traders to predict the movement of Karuna Stock. The fundamental analysis module provides a way to measure Karuna Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Karuna Therapeutics stock.
Karuna |
Karuna Therapeutics Company Equity Positions Weight Analysis
Karuna Therapeutics' Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
CompetitionAccording to the company disclosure, Karuna Therapeutics has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
All Next | Launch Module |
Karuna Fundamentals
Return On Equity | -0.36 | |||
Return On Asset | -0.25 | |||
Operating Margin | (755.64) % | |||
Current Valuation | 11.35 B | |||
Shares Outstanding | 38.2 M | |||
Shares Owned By Insiders | 4.98 % | |||
Shares Owned By Institutions | 86.32 % | |||
Number Of Shares Shorted | 1.97 M | |||
Price To Earning | (19.88) X | |||
Price To Book | 10.05 X | |||
Price To Sales | 19,265 X | |||
Revenue | 654 K | |||
Gross Profit | 10.64 M | |||
EBITDA | (493.08 M) | |||
Net Income | (433.68 M) | |||
Cash And Equivalents | 407.41 M | |||
Cash Per Share | 13.60 X | |||
Total Debt | 16.69 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 17.77 X | |||
Book Value Per Share | 32.94 X | |||
Cash Flow From Operations | (385.82 M) | |||
Short Ratio | 3.60 X | |||
Earnings Per Share | (11.74) X | |||
Price To Earnings To Growth | 1.46 X | |||
Target Price | 324.17 | |||
Number Of Employees | 339 | |||
Beta | 1.15 | |||
Market Capitalization | 12.6 B | |||
Total Asset | 1.34 B | |||
Retained Earnings | (997.89 M) | |||
Working Capital | 1.25 B | |||
Current Asset | 6.24 M | |||
Current Liabilities | 8.73 M | |||
Net Asset | 1.34 B |
About Karuna Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Karuna Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Karuna Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Karuna Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Karuna Stock
If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |